Latest news

Media
Latest news
Newsletters

Media

Gazetawroclawska.pl: Save hundreds of zlotys. Registration opens for almost free spaying of female dogs in Wrocław

Dog guardians in Wrocław have a chance to save a significant amount of money. Registration has opened for a program...

Read more

Wroclawskiefakty.pl: Wrocław-based company seeks young female dogs for free sterilization

Another round of the free spay program for female dogs is launching in Wrocław, organized by a local biotechnology company....

Read more

Wroclife.pl: Free dog sterilization in exchange for material used in the development of veterinary medicines

Sterilizing companion animals is an effective way to curb uncontrolled population growth. For years, such procedures have been funded by...

Read more

Naszemiasto.pl: Free dog sterilization in Wrocław. Who can take part in the Bioceltix program and how to sign up?

Free spay procedures for female dogs are launching in Wrocław as part of the “Sterilization Campaign” by Bioceltix. The program...

Read more

Mycompanypolska.pl: Bioceltix will obtain almost PLN 53 million for the construction of a new stem cell factory

As a result of the successful share offering, we will raise nearly PLN 53 million. These funds will be used,...

Read more

Puls Biznesu: Funding needed for dog medications. Bioceltix seeks capital again

Dr. Paweł Wielgus, Eng., spoke with Puls Biznesu about current plans to raise capital for the construction of a new...

Read more

Latest news

Bioceltix Receives Environmental Approval for the Construction of a New Stem Cell Manufacturing Facility

The environmental decision issued by the Mayor of Wrocław marks a key milestone in the implementation of the most important...

Read more

Bioceltix’s share offering is a success. The company will raise nearly PLN 53 million to build a new stem cell facility.

Bioceltix will raise nearly PLN 53 million gross, among other things, for the construction of a plant for veterinary medicinal...

Read more

Bioceltix SA shareholders have approved the share issue. The company plans to raise approximately PLN 45 million for the construction of a new stem cell facility.

Bioceltix, a publicly traded biotechnology company with a veterinary profile, received shareholder support for an issue of up to 457,000...

Read more

Bioceltix S.A. plans to finance part of the costs of the ongoing construction of a pharmaceutical plant through the issue of shares

A publicly traded biotechnology company developing veterinary medicines for companion animals is working with contracted subcontractors to build a large-scale...

Read more

Bioceltix SA announces the success of a clinical trial of a product for atopic dermatitis in dogs. The company is one step closer to registering a breakthrough drug.

A veterinary biotech company listed on the Warsaw Stock Exchange (GPW) has published the final results of a clinical trial...

Read more

Bioceltix is ​​initiating the registration process for a drug for equine arthritis. The company has submitted an application to the European Medicines Agency.

Another important milestone in the history of Bioceltix. The publicly traded veterinary company has submitted an application to the European...

Read more

Newsletters

PLN 53 million for strategy implementation and construction of a new production plant

Good morning, Poland is a leading pet-friendly country. According to a FEDIAF report, the percentage of households with at least...

Read more

Two medicines with EMA, grant awarded, webinar

Good morning, the latest report from GlobalPETS shows that we are not cutting back on the health and wellbeing of...

Read more

Atopic dermatitis drug, dialogue with the EMA, mission to the USA

Good morning, we are on the verge of registering BCX-CM-J for osteoarthritis in dogs. BCX-EM for arthritis in horses has...

Read more

A new year, the same consistency!

Good morning! This will be a favorable year for us in many respects. Thanks to the achievement of last year’s...

Read more
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.